Case Report on Anti-Tubercular Drug Induced Hepatoxicity / Modified ATT
M Saru Khan1★, Basil Sunny2, Rithuvaren M Krishnan3★ Corresponding author
- 1Department of Pharmacy Practice, Annai JKK Sampoorani Ammal College of Pharmacy, Erirmedu, Namakkal, Tamil Nadu, INDIA.
- 2Manager and Clinical Pharmacologist of Sun Rise Hospital, Kochi, Kerala, INDIA.
- 3Annai JKK Sampoorani Ammal College of Pharmacy, Tamil Nadu, INDIA.
CORRESPONDENCE
M Saru Khan
Department of Pharmacy Practice, Annai JKK Sampoorani Ammal College of Pharmacy, Erirmedu, Namakkal, Tamil Nadu, INDIA.
Volume 14, Issue 4 · pp. 294–297 · PUBLISHED · DOI: 10.5530/ijopp.14.4.59
ABSTRACT
This case summary focusing on a 67-year male patient admitted in Sun rise Hospital, Kochi with k/c/o active tubercular on cat.2 ATT, now patient came complaint with c/o decreased appetite, food intake, nausea, vomiting and excessive fatigability. The patient was received first line anti tubercular drugs 6 months back RHZE (Rifampin, Pyrazinamide, Ethambutol, and Isoniazid) and discontinued medication 2 months back. Now it is developed a severe hepatitis which is an adverse drug reaction of the Antitubercular drugs.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Khan, M. S., Sunny, B., & Krishnan, R. M. (). Case Report on Anti-Tubercular Drug Induced Hepatoxicity / Modified ATT. Indian Journal of Pharmacy Practice, 14(4), 294–297. https://doi.org/10.5530/ijopp.14.4.59
